BOSTON - Dana-Farber Cancer Institute investigators report they have discovered a type of immune antibody that can rapidly evolve to neutralize a wide array of influenza virus strains - including those the body hasn't yet encountered.
The body's ability to make the adaptable antibody suggests potential strategies for creating improved or even "universal" influenza vaccines, according to a team led by Wayne A. Marasco, MD, PhD, a cancer immunologist and virologist at Dana-Farber, reporting in the journal Nature Communications.